Search

everythinglearnresearchcommunity

for

Search:↓

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

This therapy effectively treats resistant alopecia areata with minimal side effects.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Rubbing calcipotriol on the skin works better than taking vitamin D pills for treating mild to moderate alopecia areata.

Corticosteroids may not effectively control oxidative stress in alopecia areata, possibly leading to relapses.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

People with alopecia areata often have lower vitamin D levels than healthy people.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.